🔎 Trials Near Me

Hjem › Plateepitelcancer i hode og hals › Nebraska › Omaha

Kliniske studier for Plateepitelcancer i hode og hals i Omaha, NE

13 studier for Plateepitelcancer i hode og hals søker deltakere på steder i og rundt Omaha (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

RekruttererFase 3
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
  • Nebraska Medicine-Bellevue, Bellevue · 9 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06992427

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

RekruttererFase 1
  • Exelixis Clinical Site #2, Omaha
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05176483

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

RekruttererFase 1/2
  • Nebraska Cancer Specialists, Omaha
  • XCancer, Omaha
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07189871

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

RekruttererFase 2
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
  • Nebraska Medicine-Bellevue, Bellevue · 9 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05136196

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

RekruttererFase 2
  • Nebraska Methodist Hospital, Omaha
  • Heartland Oncology and Hematology LLP, Council Bluffs · 4 mi unna
  • Methodist Jennie Edmundson Hospital, Council Bluffs · 4 mi unna
Alder 18 til 79 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT04671667

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

RekruttererFase 1/2
  • Nebraska Cancer Specialists, Omaha
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07109726

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

RekruttererFase 2
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
  • Nebraska Methodist Hospital, Omaha
  • Alegent Health Immanuel Medical Center, Omaha
  • og 5 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT02734537

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

RekruttererFase 2
  • Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
Alder 18 og eldre · Alle kjønn · Oppdatert 21. aug. 2026 · NCT06769698

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

RekruttererFase 2/3
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
  • Nebraska Methodist Hospital, Omaha
  • Heartland Oncology and Hematology LLP, Council Bluffs · 4 mi unna
  • og 1 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04333537

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

RekruttererFase 1/2
  • Nebraska Cancer Specialists, Omaha
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jul. 2026 · NCT04198766

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

RekruttererFase 3
  • GSK Investigational Site, Omaha
Alder 18 og eldre · Alle kjønn · Oppdatert 26. mai 2026 · NCT06256588

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

RekruttererFase 1/2
  • Nebraska Cancer Specialists, Omaha
Alder 18 og eldre · Alle kjønn · Oppdatert 18. feb. 2026 · NCT07030257

Plateepitelcancer i hode og hals-studier i andre byer

Andre studier i Omaha

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.